SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

cryan terence james

(Last)

(First)

(Middle)

2 HAMPSHIRE RD

(Street)

BRONXVILLE

10708

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
URANIUM RESOURCES INC /DE/ [ URRE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Interim President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2013

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock Par value $0.001								100⁽⁶⁾	I	By spouse in IRA
Common Stock Par value $0.001	03/05/2013		X		1,000	A	$2.55	19,433⁽⁴⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to buy)	$29.7⁽⁶⁾							10/03/2007⁽¹⁾	10/03/2016	Common stock	5,000⁽⁶⁾		5,000⁽⁶⁾	D
Stock option (right to buy)	$92.5⁽⁶⁾							04/10/2007⁽²⁾	04/10/2017	Common stock	10,000⁽⁶⁾		10,000⁽⁶⁾	D
Stock option (right to buy)	$113.2⁽⁶⁾							07/12/2008	07/12/2017	Common stock	5,000⁽⁶⁾		5,000⁽⁶⁾	D
Stock option (right to buy)	$41⁽⁶⁾							06/04/2009⁽¹⁾	06/04/2018	Common stock $0.001 par value	5,000⁽⁶⁾		5,000⁽⁶⁾	D
Stock option (right to buy)	$14.9⁽⁶⁾							06/03/2010⁽¹⁾	06/03/2019	Common stock	5,000⁽⁶⁾		5,000⁽⁶⁾	D
Stock option (right to buy)	$17.3⁽³⁾⁽⁶⁾							06/07/2012⁽³⁾	06/07/2021	Common stock (par value $0.001)	1,666⁽³⁾⁽⁶⁾		1,666	D
Stock Option (Right to buy)	$5.1⁽⁶⁾							⁽⁵⁾	09/28/2022	Common stock	20,000⁽⁶⁾		20,000⁽⁶⁾	D
Subscription rights (right to buy)	$2.55	03/05/2013		X		1,000⁽⁷⁾		01/28/2013	02/27/2013	Common stock	1,000⁽⁷⁾	$0	0	D

Explanation of Responses:

1. Stock options issued under the 2004 Directors Plan. Shares vest 25% per year beginning one year after date or grant.

2. Stock options granted 04/10/2007 subject to shareholder approval which was received 07/12/07. Shares vest 50% on date of grant 50% on 04/10/2008.

3. A stock option right to purchase 1,666 shares of common stock was granted on June 7, 2011 under the Directors Stock Option and Restricted Stock Plan at the 06/07/2011 Annual Stockholders Meeting. Such grant was made in lieu of the 5,000 option grant scheduled for each director at the June 7, 2011 Annual Stockholders Meeting. The stock options vest 25% per year on June 7, 2012 2013, 2014 and 2015.

4. 5,000 shares of restricted common stock were granted on September 28, 2012 under the Directors Stock Option and Restricted Stock Plan in connection with Mr. Cryan assuming the duties of Interim President and CEO. The restricted shares vest 50% on 9/28/2012 and 50% upon the hire of a permanent President and CEO for the Company.

5. A stock option right to purchase 20,000 shares of common stock at the price of $5.10 per share was granted on September 28, 2012 in connection with Mr. Cryan assuming the duties of Interim President and CEO. The stock options will vest 25% on 3/28/2013, 25% on 9/28/2013, 25% on 3/28/2014 and 25% on 9/28/2014.

6. Share amounts and per share price have been restated to reflect the 1-for-10 reverse stock split for URRE which was made effective January 22, 2013.

7. Includes shares of common stock acquired pursuant to the exercise of an over subscription privilege.

	Terence J. Cryan	03/07/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.